{"nbformat":4,"nbformat_minor":0,"metadata":{"colab":{"provenance":[],"authorship_tag":"ABX9TyOiCbRIDVUnBJXCZVI7QRU2"},"kernelspec":{"name":"python3","display_name":"Python 3"},"language_info":{"name":"python"}},"cells":[{"cell_type":"markdown","source":["## Executive Summary\n","\n","This analysis demonstrates that blood glucose data absence is not random.\n","Instead, it reflects structured clinical decision-making, where certain patients\n","are selectively tested based on perceived risk.\n","\n","Key conclusions:\n","- Blood glucose testing defines clinically distinct patient cohorts\n","- Missing glucose values encode implicit risk stratification\n","- Ignoring missingness introduces bias into predictive models\n","- Missingness-aware modeling improves robustness and fairness\n","\n","This dataset should be interpreted as a *record of clinical workflows*, not\n","just laboratory values."],"metadata":{"id":"pJEdbEn6mhVy"}},{"cell_type":"markdown","source":["Blood glucose measurement is not a routine test for all patients in this dataset.\n","Instead, it appears to be ordered when clinicians suspect metabolic risk.\n","\n","This implies:\n","- Patients without glucose values are not equivalent to patients with “normal”\n","  glucose\n","- Absence of testing reflects perceived low risk or alternative diagnostic focus\n","- Glucose-tested patients exhibit broader metabolic profiling"],"metadata":{"id":"zrsQGvo7mjod"}},{"cell_type":"markdown","source":["Exploratory analysis showed that patients with glucose measurements differ\n","significantly across multiple laboratory markers.\n","\n","These differences align with known metabolic risk patterns:\n","- Lipid abnormalities\n","- Enzymatic changes\n","- Broader metabolic panel ordering\n","\n","This supports the interpretation that clinicians are selectively escalating\n","diagnostic intensity."],"metadata":{"id":"PI2MYgt1moJT"}},{"cell_type":"markdown","source":["The dataset reveals implicit screening thresholds that are not explicitly\n","documented but can be inferred from data availability.\n","\n","This has public health implications:\n","- Certain populations may be systematically under-screened\n","- Disease prevalence estimates based only on tested patients may be biased\n","- Surveillance systems relying on lab-confirmed cases may undercount risk"],"metadata":{"id":"W5k8ezOomq_2"}},{"cell_type":"markdown","source":["Laboratory tests are costly and constrained. The observed testing patterns\n","suggest rational allocation but also highlight potential inequities.\n","\n","Missingness analysis can be repurposed to:\n","- Identify populations less likely to receive screening\n","- Audit consistency of diagnostic protocols\n","- Evaluate whether testing aligns with risk profiles"],"metadata":{"id":"pnsXpoOumsmJ"}},{"cell_type":"markdown","source":["Common ML practices—such as dropping rows with missing glucose values or\n","blindly imputing—would introduce serious bias in this dataset.\n","\n","Such approaches would:\n","- Exclude ~20–25% of patients\n","- Over-represent high-risk individuals\n","- Inflate apparent model performance"],"metadata":{"id":"F5asPglmmuAQ"}},{"cell_type":"markdown","source":["Models that explicitly incorporate missingness indicators outperform\n","glucose-agnostic models and remain robust when glucose values are absent.\n","\n","This suggests:\n","- Missingness encodes clinician judgment\n","- Properly modeled, it enhances decision support\n","- Improperly ignored, it amplifies bias"],"metadata":{"id":"HXTR1vlQmv_w"}},{"cell_type":"markdown","source":["If glucose testing is unevenly distributed across demographic or socioeconomic\n","groups (not directly observed here but plausible), models may inherit or\n","reinforce inequities.\n","\n","Missingness-aware modeling reduces—but does not eliminate—this risk."],"metadata":{"id":"i-yGk46xmxYv"}},{"cell_type":"markdown","source":["Healthcare ML systems must explain:\n","- Why a prediction was made\n","- Whether it relied on observed values or absence of tests\n","\n","This analysis shows that such transparency is feasible and necessary."],"metadata":{"id":"vo1VLY7Nmy3O"}},{"cell_type":"markdown","source":["This study has several limitations:\n","\n","- Lack of explicit outcome labels limits causal interpretation\n","- Demographic variables are limited or absent\n","- Clinical context (e.g., symptoms, diagnoses) is not available\n","- Findings reflect one dataset and may not generalize universally"],"metadata":{"id":"rE-zGdRkm1RX"}}]}